Myomo (MYO) Capital Expenditures (2017 - 2025)
Myomo (MYO) posted Capital Expenditures of $1.1 million for Q3 2025, down 16.26% on a QoQ basis from $1.3 million in Q2 2025, and up 228.3% year-over-year from $320704.0 in Q3 2024.
Myomo (MYO) Capital Expenditures (2017 - 2025) Analysis & Trends
Myomo's Capital Expenditures history runs 9 years deep, the most recent figure standing at $1.1 million for Q3 2025.
- Quarterly Capital Expenditures rose 228.3% year-over-year to $1.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $3.8 million (up 622.64% YoY) and the FY2024 annual result came in at $1.4 million, up 832.77% from the prior year.
- Capital Expenditures was $1.1 million for Q3 2025 at Myomo, down from $1.3 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.3 million in Q2 2025 and bottomed at $3385.0 in Q4 2022.
- A 5-year average of $259215.2 and a median of $54093.0 in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures slumped 89.55% — and 2024, when it soared 2616.72%.
- Myomo's Capital Expenditures stood at $23935.0 in 2021, then plunged by 85.86% to $3385.0 in 2022, then jumped by 835.45% to $31665.0 in 2023, then surged by 2616.72% to $860248.0 in 2024, then grew by 22.39% to $1.1 million in 2025.
- Business Quant data shows MYO's Capital Expenditures at $1.1 million in Q3 2025, $1.3 million in Q2 2025, and $670688.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.05 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 670,688.00 |
| Mar 31, 2025 | 670,688.00 |
| Dec 31, 2024 | 860,248.00 |
| Dec 31, 2024 | 860,248.00 |
| Sep 30, 2024 | 320,704.00 |
| Sep 30, 2024 | 320,704.00 |
| Jun 30, 2024 | 119,365.00 |
| Jun 30, 2024 | 119,365.00 |
| Mar 31, 2024 | 59,808.00 |
| Mar 31, 2024 | 59,808.00 |
| Dec 31, 2023 | 31,665.00 |
| Dec 31, 2023 | 31,665.00 |
| Sep 30, 2023 | 54,093.00 |
| Sep 30, 2023 | 54,093.00 |
| Jun 30, 2023 | 14,973.00 |
| Jun 30, 2023 | 14,973.00 |